Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01724723
What this trial is testing

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment

Who this might be right for
HepatitisTuberculosishepatitisB
National Taiwan University Hospital 50
Not applicableNot Yet RecruitingNCT06846645
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Who this might be right for
Single Cell Sequencing TechnologyGene Expression ProfilingGene Expression+7 more
Chinese University of Hong Kong 200
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Testing effectiveness (Phase 2)Study completedNCT01691534
What this trial is testing

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 105
Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 127
Early research (Phase 1)Study completedNCT01033929
What this trial is testing

A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active Tuberculosis

Who this might be right for
Tuberculosis
Statens Serum Institut 38
Not applicableEnded earlyNCT00737724
What this trial is testing

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Who this might be right for
HIVAIDSTuberculosis
Instituto Nacional de Enfermedades Respiratorias 63
Testing effectiveness (Phase 2)Study completedNCT01936831
What this trial is testing

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 282
Not applicableStudy completedNCT01130311
What this trial is testing

Replacement of Vitamin D in Patients With Active Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Aga Khan University 259
Testing effectiveness (Phase 2)Study completedNCT01241188
What this trial is testing

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)

Who this might be right for
Tuberculosis
Statens Serum Institut 253
Not applicableEnded earlyNCT02898623
What this trial is testing

Serological Test for the Diagnosis of TB

Who this might be right for
Active Tuberculosis
University Hospital, Montpellier 1,000
Not applicableStudy completedNCT04973371
What this trial is testing

Acceptability and Feasibility of Home-based TB Testing

Who this might be right for
Tuberculosis, PulmonaryHouseholds
Foundation for Professional Development (Pty) Ltd 98
Not applicableLooking for participantsNCT06971952
What this trial is testing

Tuberculosis in Rural and Malnourished Populations

Who this might be right for
Tuberculosis (TB)Undernutrition
University of Virginia 360
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Not applicableUnknownNCT02653404
What this trial is testing

IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection

Who this might be right for
Tuberculosis, PulmonaryInterferon-gamma Release TestsTuberculin Test
University of Siena 50
Not applicableActive Not RecruitingNCT05045391
What this trial is testing

Pulmonary Aspergillosis in Tuberculosis Patients

Who this might be right for
Pulmonary TuberculosesAspergillosisOld Tuberculosis+2 more
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan 200
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Not applicableStudy completedNCT00463086
What this trial is testing

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Who this might be right for
TuberculosisLatent Tuberculosis InfectionHIV Infections
University of Cape Town 1,368
Not applicableStudy completedNCT00023439
What this trial is testing

TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

Who this might be right for
Tuberculosis
Centers for Disease Control and Prevention 300
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132
Next Page